Autonomix: Advancing Microchip-Based Cancer Pain Platform with Clear Regulatory Path and Attractive Risk-Reward
at www.tipranks.com (Sat, 14-Feb 3:35 PM)
Rapid, Lasting Pain Relief in Pancreatic Cancer: AMIX Unveils Promising PoC Study Data at 2026 ASCO GI Symposium
Market Chameleon (Fri, 9-Jan 10:34 AM)
European Patent Expands Autonomix Medical’s Precision Nerve Therapy Platform
Market Chameleon (Tue, 30-Dec 9:52 AM)
AMIX’s Targeted Ablation Therapy Shows Meaningful Quality of Life Gains in Advanced Pancreatic Cancer—Subgroup Results Signal Broader Impact
Market Chameleon (Mon, 17-Nov 9:52 AM)
